Pharmaceuticals
The pharmaceutical industry is under increasing pressure to deliver and communicate value to regulators, healthcare providers and patients. In addition, companies struggle with managing the variability caused by product lifecycles, reactive governments, and increasing consumer influence on healthcare policy. Rising development costs, increased competition, and intensified pricing pressure mean that pharmaceutical companies must work harder to maintain robust pipelines, improve internal efficiency, and secure market access.
The Emerton team is able to help pharmaceutical companies rapidly augment their resources to better respond to business and market variability. Our team has worked across a broad range of therapeutic segments and geographic markets. We are able to support with:
Strategy
- Corporate and business unit strategic planning
- Portfolio and pipeline strategy
- Product launch strategy
- Digital transformation strategy, including 2D to 3D
- International market prioritization and expansion
- Pricing and reimbursement strategy
- Organizational design and governance
Market intelligence
- Market opportunity assessment
- Competitive environment assessment
- Clinical practice assessment
- Customer needs assessment
Performance improvement
- Pricing optimization
- Salesforce effectiveness improvement
- Distributor management and channel strategy
- Organizational change management and implementation support
- Executional support for product launches
Transaction support
- Company and product due-diligence
- In / out-licensing support
- Business case development
- Value sharing analysis
- Valuation
- Deal term benchmarking
- Real-time negotiation support
Government affairs
- Pricing and reimbursement dossier support
- Policy guideline development and positioning statements
- White paper development
- Policy impact assessments
- Global healthcare systems benchmarking
- Key opinion leader development and advocacy
- Industry liaison / stakeholder coordination
